Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baris Gencer

Showing results (31-40 of 179) with videos related to

Pageof 18
Sort By:
European Journal of Clinical Investigation|September 11, 2024
Routine beta-blocker therapy after acute coronary syndromes: The end of an era?Nicolas Johner, Baris Gencer, Marco Roffi
The American Journal of Medicine|December 21, 2020
The ReplyBaris Gencer, Douglas C Bauer, Nicolas Rodondi
Revue Medicale Suisse|April 20, 2016
[Recommendations for management of dyslipidemia in 2016 in Switzerland]Carole E Aubert, Baris Gencer, Nicolas Rodondi
European Journal of Preventive Cardiology|June 7, 2026
Does HDL-C matter when predicting risk of cardiovascular disease in older people with type 2 diabetes?Baris Gencer, Valerie Aponte Ribero, Orestis Efthimiou
Swiss Medical Weekly|November 3, 2015
Use and role of monoclonal antibodies and other biologics in preventive cardiologyBaris Gencer, Reijo Laaksonen, Aliki Buhayer, et al.
Revue Medicale Suisse|March 5, 2026
[Controversies in familial dyslipidemias and cardiovascular genetics in 2026]Maximilien Fleury, Elisavet Moutzouri, Baris Gencer, et al.
European Heart Journal|March 23, 2017
Subclinical thyroid dysfunction and cardiovascular diseases: 2016 updateCarmen Floriani, Baris Gencer, Tinh-Hai Collet, et al.
European Heart Journal|March 23, 2017
Lipoprotein(a): the revenantBaris Gencer, Florian Kronenberg, Erik S Stroes, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 17, 2023
In-hospital initiation of PCSK9 inhibitors in ACS: pros and consKonstantin A Krychtiuk, Marc J Claeys, Baris Gencer, et al.
Revue Medicale Suisse|March 22, 2011
[Thrombotic risk in assisted reproductive technology]Adriano Alatri, Bruno Tribout, Baris Gencer, et al.
Pageof 18

Showing results (31-40 of 179) with videos related to

Sort By:
Pageof 18
European Journal of Clinical Investigation|September 11, 2024
Routine beta-blocker therapy after acute coronary syndromes: The end of an era?Nicolas Johner, Baris Gencer, Marco Roffi
The American Journal of Medicine|December 21, 2020
The ReplyBaris Gencer, Douglas C Bauer, Nicolas Rodondi
Revue Medicale Suisse|April 20, 2016
[Recommendations for management of dyslipidemia in 2016 in Switzerland]Carole E Aubert, Baris Gencer, Nicolas Rodondi
European Journal of Preventive Cardiology|June 7, 2026
Does HDL-C matter when predicting risk of cardiovascular disease in older people with type 2 diabetes?Baris Gencer, Valerie Aponte Ribero, Orestis Efthimiou
Swiss Medical Weekly|November 3, 2015
Use and role of monoclonal antibodies and other biologics in preventive cardiologyBaris Gencer, Reijo Laaksonen, Aliki Buhayer, et al.
Revue Medicale Suisse|March 5, 2026
[Controversies in familial dyslipidemias and cardiovascular genetics in 2026]Maximilien Fleury, Elisavet Moutzouri, Baris Gencer, et al.
European Heart Journal|March 23, 2017
Subclinical thyroid dysfunction and cardiovascular diseases: 2016 updateCarmen Floriani, Baris Gencer, Tinh-Hai Collet, et al.
European Heart Journal|March 23, 2017
Lipoprotein(a): the revenantBaris Gencer, Florian Kronenberg, Erik S Stroes, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 17, 2023
In-hospital initiation of PCSK9 inhibitors in ACS: pros and consKonstantin A Krychtiuk, Marc J Claeys, Baris Gencer, et al.
Revue Medicale Suisse|March 22, 2011
[Thrombotic risk in assisted reproductive technology]Adriano Alatri, Bruno Tribout, Baris Gencer, et al.
Pageof 18